Cited by 238Protein Structure and DynamicsMonoclonal and Polyclonal Antibodies ResearchEnzyme Structure and Function

ABodyBuilder: automated antibody structure prediction with data-driven accuracy estimation

Open access
Leem, Jinwoo, Dunbar, James, Georges, Guy, Shi, Jiye, Deane, Charlotte M.·2016·mAbs

Abstract

Computational modeling of antibody structures plays a critical role in therapeutic antibody design. Several antibody modeling pipelines exist, but no freely available methods currently model nanobodies, provide estimates of expected model accuracy, or highlight potential issues with the antibody's experimental development. Here, we describe our automated antibody modeling pipeline, ABodyBuilder, designed to overcome these issues. The algorithm itself follows the standard 4 steps of template selection, orientation prediction, complementarity-determining region (CDR) loop modeling, and side chain prediction. ABodyBuilder then annotates the 'confidence' of the model as a probability that a component of the antibody (e.g., CDRL3 loop) will be modeled within a root-mean square deviation threshold. It also flags structural motifs on the model that are known to cause issues during in vitro development. ABodyBuilder was tested on 4 separate datasets, including the 11 antibodies from the Antibody Modeling Assessment-II competition. ABodyBuilder builds models that are of similar quality to other methodologies, with sub-Angstrom predictions for the 'canonical' CDR loops. Its ability to model nanobodies, and rapidly generate models (∼30 seconds per model) widens its potential usage. ABodyBuilder can also help users in decision-making for the development of novel antibodies because it provides model confidence and potential sequence liabilities. ABodyBuilder is freely available at http://opig.stats.ox.ac.uk/webapps/abodybuilder .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19420862.2016.1205773

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ABodyBuilder is an automated antibody homology modeling pipeline that follows four steps: template selection, orientation prediction, CDR loop modeling, and side chain prediction.

    “For example, ABodyBuilder [41], an automated antibody homology modeling pipeline, follows four steps: template selection, orientation prediction, CDR loop modeling, and side chain prediction.”
  • DeepAb achieved a prediction accuracy for H3 loop at RMSD of 2.33 Å while ABlooper and ABodyBuilder achieved RMSD of 2.49 Å and 3.25 Å, respectively.

    “In the end, DeepAb achieved a prediction accuracy for H3 loop at rootmean-square deviation (RMSD) of 2.33 Å while ABlooper and ABodyBuilder achieved RMSD of 2.49 Å and 3.25 Å, respectively [41].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Leem, J., Dunbar, J., Georges, G., Shi, J., & Deane, C. M.
Affiliations
  • University of Oxford (GB)
  • Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany
  • UCB Pharma (United Kingdom) (GB)
Corresponding author
Deane, Charlotte M.
Venue
mAbs
Published
2016-08-30
Volume
8
Issue
7
Pages
1259-1268
ISSN
  • 1942-0862 (ISSN-L)
  • 1942-0870
OpenAlex
W2474661075
Cited by
238
References
47
Citations by year
2026: 11 · 2025: 24 · 2024: 37 · 2023: 39 · 2022: 44 · 2021: 27 · 2020: 17 · 2019: 19 · 2018: 12 · 2017: 8
FWCI
6.75
Type
journal article
Language
en
Open access
Locations
  • mAbs (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Engineering and Physical Sciences Research Council (1231608)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
Keywords
antibody structure prediction, template selection, structural motifs
MeSH terms
Algorithms, Antibodies, Computer Simulation, Models, Molecular, Drug Design, Complementarity Determining Regions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review